Wound Care (Pharmacies) - Ireland

Ireland

Highlights

Revenue in the Wound Care market is projected to reach US$8.65m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.39%, resulting in a market volume of US$9.27m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$1.70 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in Ireland is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences play a crucial role in driving the growth of the Wound Care (Pharmacies) market in Ireland. Consumers are increasingly seeking convenient and accessible healthcare solutions, and pharmacies provide a convenient location for purchasing wound care products. Additionally, there is a growing demand for advanced wound care products that offer superior healing properties and promote faster recovery. These preferences are driving the expansion of the market as pharmacies strive to meet the evolving needs of their customers. Trends in the market further contribute to the development of the Wound Care (Pharmacies) market in Ireland. One notable trend is the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, due to the aging population and the rising incidence of diabetes. This trend creates a higher demand for wound care products and services, leading to market growth. Additionally, there is a growing focus on the use of innovative technologies in wound care, such as advanced dressings and negative pressure wound therapy. These advancements in wound care technology drive market expansion as pharmacies stock and offer these cutting-edge products to their customers. Local special circumstances also impact the development of the Wound Care (Pharmacies) market in Ireland. The country has a well-established healthcare system that emphasizes community-based care, with pharmacies playing a crucial role in providing accessible healthcare services. This emphasis on community healthcare creates a favorable environment for the growth of the Wound Care (Pharmacies) market, as pharmacies are seen as trusted and reliable sources for wound care products and advice. Additionally, the presence of a large number of pharmacies throughout the country ensures easy access to wound care products for the population. Underlying macroeconomic factors further contribute to the growth of the Wound Care (Pharmacies) market in Ireland. The country has a stable economy with a high standard of living, which enables consumers to afford and prioritize their healthcare needs. Additionally, the government's focus on healthcare and the provision of universal healthcare coverage ensures that individuals have access to wound care products and services. These macroeconomic factors create a favorable environment for the development of the Wound Care (Pharmacies) market in Ireland. In conclusion, the Wound Care (Pharmacies) market in Ireland is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility of pharmacies, the increasing demand for advanced wound care products, the prevalence of chronic wounds, the emphasis on community healthcare, and the stable economy all contribute to the positive trajectory of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.